# DESCRIPTION

## BACKGROUND OF THE INVENTION

- discuss HIV vaccine development challenges

## BRIEF SUMMARY OF THE INVENTION

- introduce expression vector for HIV Env glycoproteins

## DETAILED DESCRIPTION OF THE INVENTION

- define expression vector
- describe HIV Env glycoprotein
- describe furin protease
- outline expression vector components
- discuss promoters for expression vector
- provide examples of promoters
- describe promoter activity
- specify expression vector transfection
- integrate expression vector into host genome
- produce cleaved HIV Env glycoproteins
- purify and analyze Env glycoproteins

### EXAMPLE 1

- design vector co-expressing Env glycoprotein and furin protease

### EXAMPLE 2

- select and propagate stable cell lines expressing Env glycoprotein

### EXAMPLE 3

- demonstrate sustained intracellular Env glycoprotein expression

### EXAMPLE 4

- purify and characterize BG505 SOSIP.664 gp140 trimers
- compare yields and quality of trimers from stable cell lines vs. transient transfection
- analyze trimer stability and resistance to proteolytic degradation

### EXAMPLE 5

- analyze BG505 SOSIP.664 gp140 trimers by surface plasmon resonance and ELISA

### EXAMPLE 6

- image BG505 SOSIP.664 gp140 trimers by electron microscopy

### EXAMPLE 7

- analyze thermal stability of trimers by differential scanning calorimetry

### EXAMPLE 8

- modify env genes derived from HIV subtype B and subtype C

### EXAMPLE 9

- express B41 SOSIP.664 Env glycoproteins
- purify Env proteins using 2G12 bNAb and SEC
- analyze purified trimers by BN PAGE and SDS-PAGE
- observe V3-clipping of B41 SOSIP.664 trimers
- produce non-clipped trimers using 293F cells in serum-free medium
- demonstrate production and purification of B41 SOSIP.664 trimers

